| P2093 | author name string | J A Berzofsky | |
| | C L Mackall | |
| | T J Goletz | |
| | L J Helman | |
| P2860 | cites work | Chromosome translocation in peripheral neuroepithelioma | Q71438112 |
| | Improved induction of melanoma-reactive CTL with peptides from the melanoma antigen gp100 modified at HLA-A*0201-binding residues | Q71527769 |
| | Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2 | Q72052802 |
| | Fusion of the EWS and WT1 genes in the desmoplastic small round cell tumor | Q72428441 |
| | Additional evidence of a variant translocation t(12;22) with EWS/CHOP fusion in myxoid liposarcoma: clinicopathological features | Q73721197 |
| | Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours | Q24298221 |
| | Transcription factor ATF cDNA clones: an extensive family of leucine zipper proteins able to selectively form DNA-binding heterodimers | Q24302559 |
| | Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma | Q24304506 |
| | Fusion of SYT to two genes, SSX1 and SSX2, encoding proteins with homology to the Kruppel-associated box in human synovial sarcoma | Q24307456 |
| | Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma | Q24309359 |
| | Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor | Q24312048 |
| | A variant Ewing's sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1 | Q24312796 |
| | The PAX3-FKHR fusion protein created by the t(2;13) translocation in alveolar rhabdomyosarcomas is a more potent transcriptional activator than PAX3 | Q24313754 |
| | A new member of the ETS family fused to EWS in Ewing tumors | Q24317176 |
| | EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts | Q24317557 |
| | The EWS gene, involved in Ewing family of tumors, malignant melanoma of soft parts and desmoplastic small round cell tumors, codes for an RNA binding protein with novel regulatory domains | Q24319886 |
| | SRE elements are binding sites for the fusion protein EWS-FLI-1 | Q24546126 |
| | Krüppel-associated boxes are potent transcriptional repression domains | Q24563259 |
| | The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1 | Q24629399 |
| | The hybrid PAX3-FKHR fusion protein of alveolar rhabdomyosarcoma transforms fibroblasts in culture | Q24632107 |
| | EWS-erg and EWS-Fli1 fusion transcripts in Ewing's sarcoma and primitive neuroectodermal tumors with variant translocations | Q24634316 |
| | SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma | Q27851510 |
| | Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma | Q28240093 |
| | Inhibition of apoptosis by normal and aberrant Fli-1 and erg proteins involved in human solid tumors and leukemias | Q28240219 |
| | A novel effector domain from the RNA-binding protein TLS or EWS is required for oncogenic transformation by CHOP | Q28240554 |
| | Characterization of the CHOP breakpoints and fusion transcripts in myxoid liposarcomas with the 12;16 translocation | Q28242489 |
| | A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG | Q28252253 |
| | Intra-abdominal desmoplastic small round-cell tumor. Report of 19 cases of a distinctive type of high-grade polyphenotypic malignancy affecting young individuals | Q50803642 |
| | Chromosomal translocations in human cancer. | Q52512616 |
| | The Ewing Family of Tumors -- A Subgroup of Small-Round-Cell Tumors Defined by Specific Chimeric Transcripts | Q57756648 |
| | MIC2 is a specific marker for ewing's sarcoma and peripheral primitive neuroectodermal tumors. Evidence for a common histogenesis of ewing's sarcoma and peripheral primitive neuroectodermal tumors from MIC2 expression and specific chromosome aberrati | Q57756690 |
| | Cloning and characterization of the Ewing's sarcoma and peripheral neuroepithelioma t(11;22) translocation breakpoints | Q60035789 |
| | A Novel Reciprocal Chromosome Translocation t(11;22)(p13;q12) in an Intraabdominal Desmoplastic Small Round-Cell Tumor | Q67487724 |
| | Reciprocal translocation t(12;22)(q13;q13) in clear-cell sarcoma of tendons and aponeuroses | Q67534089 |
| | Cytogenetic abnormalities in an intraabdominal desmoplastic small cell tumor | Q67992109 |
| | Consistent chromosomal translocation in alveolar rhabdomyosarcoma | Q69994392 |
| | Malignant melanoma of soft parts. A reassessment of clear cell sarcoma | Q71020878 |
| | Promoters containing ATF-binding sites are de-regulated in cells that express the EWS/ATF1 oncogene. | Q38295666 |
| | The oncogenic potential of Pax genes | Q38318897 |
| | Identification of target genes for the Ewing's sarcoma EWS/FLI fusion protein by representational difference analysis | Q40016977 |
| | Malignant melanoma of soft parts involving the head and neck region: review of literature and case report | Q40372503 |
| | Dominance and crypticity of T cell antigenic determinants | Q40486347 |
| | The Ets family of transcription factors | Q40871575 |
| | Combinatorial generation of variable fusion proteins in the Ewing family of tumours. | Q40874946 |
| | The biochemistry and cell biology of antigen processing and presentation | Q40898211 |
| | In vitro predictors of therapeutic response in melanoma patients receiving tumor-infiltrating lymphocytes and interleukin-2. | Q41027329 |
| | Fusion of the EWS1 and WT1 genes as a result of the t(11;22)(p13;q12) translocation in desmoplastic small round cell tumors | Q41127723 |
| | EWS/FLI-1 antagonists induce growth inhibition of Ewing tumor cells in vitro | Q41207208 |
| | Pax genes and their roles in cell differentiation and development | Q41239105 |
| | Induction and characterization of cytotoxic T-lymphocytes recognizing a mutated p21ras peptide presented by HLA-A*0201. | Q41347233 |
| | Detection of the t(2;13)(q35;q14) and PAX3-FKHR fusion in alveolar rhabdomyosarcoma by fluorescence in situ hybridization | Q41367203 |
| | Chromosome translocation-mediated conversion of a tumor suppressor gene into a dominant oncogene: fusion of EWS1 to WT1 in desmoplastic small round cell tumors. | Q41431767 |
| | The FLI-1 and chimeric EWS-FLI-1 oncoproteins display similar DNA binding specificities. | Q41455523 |
| | Fusion of PAX3 to a member of the forkhead family of transcription factors in human alveolar rhabdomyosarcoma. | Q41517584 |
| | In vitro induction of human cytotoxic T lymphocyte responses against peptides of mutant and wild-type p53. | Q41529681 |
| | Characterization of the ets oncogene family member, fli-1. | Q41565730 |
| | Detection of the (11;22)(q24;q12) translocation of Ewing's sarcoma and peripheral neuroectodermal tumor by reverse transcription polymerase chain reaction | Q42027940 |
| | CHOP (GADD153) and its oncogenic variant, TLS-CHOP, have opposing effects on the induction of G1/S arrest. | Q42801637 |
| | A mutant p53 tumor suppressor protein is a target for peptide-induced CD8+ cytotoxic T-cells | Q42808144 |
| | Multiple domains mediate transformation by the Ewing's sarcoma EWS/FLI-1 fusion gene | Q42830152 |
| | Cytogenetic findings in clear cell sarcoma of tendons and aponeuroses. Malignant melanoma of soft parts | Q43466194 |
| | Genetic immunization is a simple method for eliciting an immune response | Q43857336 |
| | Induction of anti-self-immunity to cure cancer | Q44641849 |
| | Isolation and characterization of the mouse homolog of SYT, a gene implicated in the development of human synovial sarcomas. | Q48061783 |
| | Neuroscience at risk at NSF. | Q48626355 |
| | Malignant melanoma of the soft parts (clear-cell sarcoma): confirmation of EWS and ATF-1 gene fusion caused by a t(12;22) translocation | Q49094393 |
| | Genomic structure of the EWS gene and its relationship to EWSR1, a site of tumor-associated chromosome translocation | Q28259434 |
| | EWS/Fli-1 chimeric protein is a transcriptional activator | Q28285342 |
| | CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription | Q28287446 |
| | Chromosomes in Ewing's sarcoma. I. An evaluation of 85 cases of remarkable consistency of t(11;22)(q24;q12) | Q28291773 |
| | Expression patterns of the human sarcoma-associated genes FUS and EWS and the genomic structure of FUS | Q28296815 |
| | Genomic organization of the human PAX3 gene: DNA sequence analysis of the region disrupted in alveolar rhabdomyosarcoma | Q28303210 |
| | Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. | Q30463850 |
| | Targeting p53 as a general tumor antigen | Q33638172 |
| | Erythroleukemia induction by Friend murine leukemia virus: insertional activation of a new member of the ets gene family, Fli-1, closely linked to c-ets-1. | Q34114085 |
| | Rearrangement of the PAX3 paired box gene in the paediatric solid tumour alveolar rhabdomyosarcoma | Q34334974 |
| | Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma | Q34341396 |
| | Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma | Q34347334 |
| | Differential dependence on target site tissue for gene gun and intramuscular DNA immunizations | Q34425539 |
| | Influence of interleukin 12 on p53 peptide vaccination against established Meth A sarcoma | Q34577679 |
| | Characterization of the genomic breakpoint and chimeric transcripts in the EWS-WT1 gene fusion of desmoplastic small round cell tumor | Q34676847 |
| | Multiplex RT-PCR assay for the differential diagnosis of alveolar rhabdomyosarcoma and Ewing's sarcoma. | Q35794887 |
| | Immunohistochemical analysis of Ewing's sarcoma cell surface antigen p30/32MIC2 | Q35830412 |
| | Cytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metastases. | Q36088999 |
| | Interferon gamma and tumor necrosis factor have a role in tumor regressions mediated by murine CD8+ tumor-infiltrating lymphocytes | Q36230021 |
| | Fusion genes resulting from alternative chromosomal translocations are overexpressed by gene-specific mechanisms in alveolar rhabdomyosarcoma | Q36300801 |
| | Immunotherapy of malignancy by in vivo gene transfer into tumors | Q36309790 |
| | A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes | Q36365851 |
| | Therapy of murine tumors with p53 wild-type and mutant sequence peptide-based vaccines | Q36366405 |
| | Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation. | Q36374350 |
| | DNA-binding and transcriptional activation properties of the EWS-FLI-1 fusion protein resulting from the t(11;22) translocation in Ewing sarcoma | Q36652613 |
| | Induction of apoptosis in rhabdomyosarcoma cells through down-regulation of PAX proteins. | Q36689270 |
| | Selective repression of transcriptional activators at a distance by the Drosophila Krüppel protein | Q36702540 |
| | A novel Krüppel-associated box containing the SSX gene (SSX3) on the human X chromosome is not implicated in t(X;18)-positive synovial sarcomas | Q36806784 |
| | EWS-Fli1 antisense oligodeoxynucleotide inhibits proliferation of human Ewing's sarcoma and primitive neuroectodermal tumor cells | Q37362452 |
| | Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells | Q37411183 |
| | Mechanism for transcriptional gain of function resulting from chromosomal translocation in alveolar rhabdomyosarcoma | Q37588880 |
| | Antigen recognition by class I-restricted T lymphocytes | Q38201551 |
| | The alveolar rhabdomyosarcoma PAX3/FKHR fusion protein is a transcriptional activator | Q38292755 |
| | Wild type PAX3 protein and the PAX3-FKHR fusion protein of alveolar rhabdomyosarcoma contain potent, structurally distinct transcriptional activation domains | Q38293532 |
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 2 | |
| P921 | main subject | immunotherapy | Q1427096 |
| P304 | page(s) | 77-87 | |
| P577 | publication date | 1998-01-01 | |
| P1433 | published in | Sarcoma | Q26841949 |
| P1476 | title | Molecular alterations in pediatric sarcomas: potential targets for immunotherapy | |
| P478 | volume | 2 | |